nVerses Capital’s Tenet Healthcare THC Stock Holding History

nVerses Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$13.3K	–	1383
2024 Q2	$13.3K	Buy	+100	New	+$12K	0.01%	864

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

nVerses Capital's THC Position: Q3 2024 in Review

nVerses Capital sold out of Tenet Healthcare (THC) in Q3 2024, closing a stake of 100 shares — an estimated $13.3K sold.

nVerses Capital first reported a position in THC in Q2 2024 and held it in 1 quarter. The position peaked at $13.3K in Q2 2024. 603 funds tracked by Wall St. Rank hold THC as of Q3 2024.

nVerses Capital reported no remaining Tenet Healthcare position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 100 Tenet Healthcare shares in Q3 2024, an estimated $13.3K.
nVerses Capital first reported a position in Tenet Healthcare in Q2 2024 and held it in 1 quarter.
nVerses Capital's Tenet Healthcare position peaked at $13.3K in Q2 2024.
603 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.